Search Results - "Ou, Yitao"
-
1
Sphingosine kinase 1 promotes liver fibrosis by preventing miR‐19b‐3p‐mediated inhibition of CCR2
Published in Hepatology (Baltimore, Md.) (01-09-2018)“…Chronic liver disease mediated by activation of hepatic stellate cells (HSCs) and Kupffer cells (KCs) leads to liver fibrosis. Here, we aimed to investigate…”
Get full text
Journal Article -
2
Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition
Published in Experimental cell research (15-01-2018)“…Activation of hepatic stellate cells (HSCs) is an essential event in the initiation and progression of liver fibrosis. HSCs are believed to be the major source…”
Get full text
Journal Article -
3
Chlorquinaldol Alleviates Lung Fibrosis in Mice by Inhibiting Fibroblast Activation through Targeting Methionine Synthase Reductase
Published in ACS central science (25-09-2024)“…Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease with limited treatment options. Thus, it is essential to investigate potential…”
Get full text
Journal Article -
4
Disulfiram suppresses NLRP3 inflammasome activation to treat peritoneal and gouty inflammation
Published in Free radical biology & medicine (20-05-2020)“…The NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome plays a vital role in mediating the innate immune system. Its aberrant activation…”
Get full text
Journal Article -
5
Tanshinones inhibit NLRP3 inflammasome activation by alleviating mitochondrial damage to protect against septic and gouty inflammation
Published in International immunopharmacology (01-08-2021)“…[Display omitted] •15 tanshinones suppressed NLRP3 inflammasome activation.•Tanshinones reduced mitochondrial ROS production and alleviated mitochondrial…”
Get full text
Journal Article -
6
Seratrodast, a thromboxane A2 receptor antagonist, inhibits neuronal ferroptosis by promoting GPX4 expression and suppressing JNK phosphorylation
Published in Brain research (15-11-2022)Get full text
Journal Article -
7
Synthesis and biological evaluation of parthenolide derivatives with reduced toxicity as potential inhibitors of the NLRP3 inflammasome
Published in Bioorganic & medicinal chemistry letters (01-09-2020)“…[Display omitted] Parthenolide (PTL) can target NLRP3 inflammasome to treat inflammation and its related disease, but its cytotoxicity limits further…”
Get full text
Journal Article -
8
Discovery of a selective NLRP3-targeting compound with therapeutic activity in MSU-induced peritonitis and DSS-induced acute intestinal inflammation
Published in Cellular and molecular life sciences : CMLS (01-08-2023)“…The aberrant activation of the nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3 (NLRP3) inflammasome is known to…”
Get full text
Journal Article -
9
Bortezomib inhibits NLRP3 inflammasome activation and NF-κB pathway to reduce psoriatic inflammation
Published in Biochemical pharmacology (01-12-2022)“…[Display omitted] The abnormal activation of nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing protein 3 (NLRP3)…”
Get full text
Journal Article -
10
Discovery of chalcone analogues as novel NLRP3 inflammasome inhibitors with potent anti-inflammation activities
Published in European journal of medicinal chemistry (05-07-2021)“…NLRP3 inflammasome activation plays a critical role in inflammation and its related disorders. Herein we report a hit-to-lead effort resulting in the discovery…”
Get full text
Journal Article -
11
Artemisinin-derived artemisitene blocks ROS-mediated NLRP3 inflammasome and alleviates ulcerative colitis
Published in International immunopharmacology (01-12-2022)“…[Display omitted] •Artemisitene significantly inhibits inflammasome-dependent IL-1β release.•Artemisitene can be readily semi-synthesized from…”
Get full text
Journal Article -
12
Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway
Published in Molecular and cellular endocrinology (05-12-2016)“…Diabetic nephropathy (DN) is characterized by proliferation of mesangial cells, mesangial hypertrophy and extracellular matrix (ECM) accumulation. Our recent…”
Get full text
Journal Article -
13
Discovery of a Novel Oral Proteasome Inhibitor to Block NLRP3 Inflammasome Activation with Anti-inflammation Activity
Published in Journal of medicinal chemistry (22-09-2022)“…NLRP3 inflammasome activation plays a critical role in inflammation-related disorders. More small-molecule entities are needed to study the mechanism of NLRP3…”
Get full text
Journal Article -
14
Antagonizing interleukin-5 receptor ameliorates dextran sulfate sodium-induced experimental colitis in mice through reducing NLRP3 inflammasome activation
Published in European journal of pharmacology (15-02-2024)“…Inflammatory bowel disease (IBD) is a condition characterized by inflammation in the gastrointestinal tract. Reducing intestinal inflammation is a promising…”
Get full text
Journal Article -
15
Ciclopirox inhibits NLRP3 inflammasome activation via protecting mitochondria and ameliorates imiquimod-induced psoriatic inflammation in mice
Published in European journal of pharmacology (05-09-2022)“…The maturation and secretion of interleukin-1β (IL-1β) mediated by NLRP3 inflammasome activation plays an important role in the progression of many…”
Get full text
Journal Article -
16
Chlorquinaldol inhibits the activation of nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing protein 3 inflammasome and ameliorates imiquimod-induced psoriasis-like dermatitis in mice
Published in Chemico-biological interactions (25-09-2022)“…Psoriasis is a common chronic autoinflammatory/autoimmune skin disease associated with elevated pro-inflammatory cytokines. The pivotal role of interleukin…”
Get full text
Journal Article -
17
Activation of Slit2-Robo1 signaling promotes liver fibrosis
Published in Journal of hepatology (01-12-2015)“…Background & Aims The secretory protein Slit2 and its receptor Robo1 are believed to regulate cell growth and migration. Here, we aimed to determine whether…”
Get full text
Journal Article -
18
Compound AD110 Acts as Therapeutic Management for Alzheimer’s Disease and Stroke in Mouse and Rat Models
Published in ACS chemical neuroscience (18-03-2020)“…Anti-inflammatory therapy may be an effective therapeutic intervention for neurological diseases, such as Alzheimer’s disease (AD) and stroke. As an important…”
Get full text
Journal Article -
19
-
20
Compound AD16 Reduces Amyloid Plaque Deposition and Modifies Microglia in a Transgenic Mouse Model of Alzheimer’s Disease
Published in ACS pharmacology & translational science (11-12-2020)“…Microglial dysfunction is involved in the pathological cascade of Alzheimer’s disease (AD). The regulation of microglial function may be a novel strategy for…”
Get full text
Journal Article